
A pharmacy technician prepares antibiotics in a laboratory in Paris, France, on Sept. 28, 2023. Mehdi Fedouach/AFP via Getty Images
Reports of critical antibiotic resistance in Australia jumped by more than 25 percent in 2024, prompting fresh warnings from the country’s peak medical body about the need to curb antibiotic overprescription.
The Australian Medical Association (AMA) said over 1,000 deaths in Australia were linked to hospital-acquired infections involving antimicrobial-resistant (AMR) bacteria in 2020.
“Antimicrobial resistance is not a future threat,” AMA President Dr. Michael Bonning said in a statement.
“It is here, it is growing, and it is already having devastating consequences.”
Bonning said AMR could render existing treatments ineffective while increasing the risks associated with many medical procedures, including joint replacements and caesarean sections.
“Protecting these medicines now means protecting the treatments and procedures Australians will rely on for generations to come.”
It found that only 45 percent of antibiotics prescribed following surgery were considered appropriate, while antimicrobial prescribing in residential aged care increased by 14.4 percent in 2024.
The report also found that 23.2 million antibiotic prescriptions were supplied through the Pharmaceutical Benefits Scheme in 2024, representing a 4.8 percent increase from the previous year.
“There appears to be less caution when prescribing antibiotics that are considered to have a lower risk of promoting resistance, resulting in their more frequent use even in situations where there is no clear benefit.” a spokesperson for the CDC said.
Calls for Stronger Government Action
Against this backdrop, Bonning called for stronger coordination between governments, greater investment in new treatments, and improved antimicrobial stewardship to ensure antibiotics are prescribed appropriately.
“As a GP, I know antibiotics are among the most valuable tools we have, but every unnecessary or inappropriate prescription gives resistant infections another opportunity to develop and spread,” he said.
“We need strong antimicrobial stewardship wherever these medicines are prescribed, as well as better surveillance, public awareness, and investment in new treatments.”
The rate was 28 defined daily doses per 1,000 people per day, almost double the OECD average of 15.
Meanwhile, the WHO said 173 countries had national action plans to address AMR but warned that only 22 percent reported having both the funding and full implementation necessary to carry them out.
“National plans are essential for protecting the medicines that protect us,” WHO Director-General Tedros Adhanom Ghebreyesus said.
“But an unfulfilled plan helps no one.”


